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Abstract
Myoepitheliomas of the extremity are rare and usually benign, while a minority display malignant
features. This case demonstrates the diagnosis and management of myoepithelioma within the
carpal tunnel. Clinical and radiological tumour features were evaluated. Hematoxylin and eosin
stained tumour sections were examined, and immunohistochemistry was performed. Histology
revealed a nodular mass of epithelioid cells in clusters within a myxoid/chondroid stroma. No
mitoses were noted. Cytokeratins, neuron-specific enolase, synaptophysin, glial fibrillary acidic
protein, and S100 were positive on immunohistochemistry. A literature review revealed very few
prior reports of myoepithelioma in the wrist, and limited data concerning any relationship between
recurrence and quality of surgical margins. In this case, wide local excision would have significantly
compromised dominant hand function, and therefore a marginal excision was deemed appropriate
in the context of bland histological features. Surgical margins noted in future case reports will aid
clinical decision making.
Introduction
Myoepithelioma, also known as parachordoma, is a rare
soft-tissue tumour more commonly associated with the
salivary gland [1]. It is also found in the extremities. Only
three cases have been reported in the wrist (Table 1), and
only one of these caused median nerve compression [2].
Myoepithelioma may be found attached to tendon
sheaths and shares similar radiological findings to gangli-
ons, pigmented villonodular synovitis, and extraskeletal
myxoid chondrosarcoma (ESMC). Histological diagnosis
of myoepithelioma can be difficult and the histological
criteria for malignancy are still being defined. These diffi-
culties of diagnosis and the rarity of the tumour provide a
management challenge. This case report and literature
review outlines the process of diagnosing myoepitheli-
oma in the carpal tunnel, specifically focusing on differen-
tial diagnosis and management principles.
Case presentation
A 36 year old Caucasian male presented with a mass in the
right wrist and paraesthesia in the distribution of the
median nerve. The mass had been noticed four years prior
to presentation and over this time had increased in size.
On examination the mass projected from the volar aspect
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Table 1: A summary of reported myoepithelioma/parachordoma cases in the upper limb (excluding the shoulder girdle)
Authors Site Length of 
History
Histology Surgery
(margins)
Local 
Recurrence
Metastasis
Clabeaux et al 
2008 [23]
Distal triceps 3 m Parachordoma, 
(nuclear atypia, one 
mitosis per 20 
HPF)
Wide None
(3 m post op)
None
(3 m post op)
Pilavaki et al 2007 [24]H a n d
(hypothenar, 
subcutaneous)
4 y Myoepithelioma
(no mitoses)
Excisional biopsy
(marginal margins)
None
(9 m post op)
None
(9 m post op)
Gleason and Fletcher 
2007 [5]
Hand NA Myoepithelial 
carcinoma
NA Yes
(7 y post op)
No
Wrist NA Myoepithelial 
carcinoma
NA NA NA
Hamada et al 
2006 [25]
Hand
(thenar 
eminence)
3 y Myoepithelioma NA NA None
(at diagnosis)
Harada et al 2005 [8] Forearm 14 y Myoepithelioma
(nuclear atypia, 2-3 
mitoses per 10 
HPF)
Local excisional 
biopsy
NA Lung mets
(6 m post op)
Colombat et al 
2003 [2]
Wrist 10 y Myoepithelioma Clear margins None
(5 m post op)
None
(5 m post op)
Šeparović et al 
2001 [26]
Hand 2 y Parachordoma Excisional biopsy
(unknown margins)
None
(20 m post op)
None
(20 m post op)
Folpe et al 1999 [27] 3 cases in the arm
(deep to 
superficial fascia)
NA Parachordoma
(< 1 mitosis per 20 
HPF)
NA None
(min 4 m follow 
up)
None
(min 4 m follow 
up)
Michal et al 1999 [28] Proximal thumb NA Myoepithelioma NA None
(19 y post op)
None
(19 y post op)
Imlay et al 1998 [29]F o r e a r m
(subcutaneous)
NA Parachodroma
No mitoses
NA None
(12 m post op)
None
(12 m post op)
Kilpatrick et al 
1997 [30]
Hand NA Myoepithelioma
(ductal 
differentiation, < 2 
mitoses per 10 
HPF)
NA Yes
(14 m post op)
NA
Finger 3 m Myoepithelioma
(myxoid features, < 
2 mitoses per 10 
HPF)
NA None
(2 y post op)
None
(2 y post op)
Fisher and Miettinen 
1997 [31]
Triceps 6 m Parachordoma
(rare mitoses, mild 
nuclear 
pleomorphism)
NA None
(2 y post op)
None
(2 y post op)
Wrist
(attached to 
tendon of flexor 
carpi ulnaris)
NA Parachordoma
(rare mitoses, mild 
nuclear 
pleomorphism)
NA NA NA
Nietzabitowski et al 
1995 [9]
Palm 4 y Parachordoma NA Yes
(3 m post op)
None
(23 post op)
Sangueza and White 
1994 [32]
Finger
(adjacent to 
proximal IP joint)
5 y Parachordoma
(slight nuclear 
pleomorphism, no 
mitoses)
NA NA NA
Dabska 1977 [33] Arm 7 m Parachordoma NA None
(10 y post op)
None
(10 y post op)
Distal radius 2 m Parachordoma Likely wide margins None
(6 y post op)
None
(6 y post op)
Finger NA Parachordoma Likely marginal or 
intralesional
None
(5 y post op)
None
(5 y post op)
NA (not available), y (years), m (months), HPF (high power fields)
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of the wrist but was poorly demarcated. It was firm to pal-
pate and non-tender. Hand examination revealed attach-
ment of the mass to the flexor digitorum profundus
tendon of the index finger. Paraesthesia was exacerbated
by repetitive use of all the long flexor tendons. No thenar
eminence wasting was noted but some mild clinical weak-
ness was evident in this muscle group.
An initial MRI scan performed outside our institution
demonstrated a T2 hyperintense lesion, 50 mm long by
14 mm wide, arising from the index finger profundus ten-
don within the palm and displacing the median nerve.
Thallium-201 scintigraphy (Fig. 1) demonstrated initial
tracer uptake in a small focus corresponding with the
mass described on MRI. Images at four hours post infu-
sion revealed complete washout of the abnormal tracer
activity in this region. These images indicated a likely
benign diagnosis of a ganglion or pigmented villonodular
synovitis (PVNS), while synovial sarcoma was considered
to be unlikely given the thallium washout at four hours.
A CT guided core-biopsy of the lesion was performed. The
lesion could not be aspirated and two 18 gauge cores of
gelatinous material were taken. Microscopic examination
of these cores revealed a chondroid matrix and bland cells
suggestive of synovial chondromatosis.
A second MRI scan (Fig. 2), performed 12 months later,
showed the tumour size had not changed from the previ-
ous scan and the long axis of the mass remained parallel
to that of the profundus tendon. Fluid signal was noted
predominantly but with the addition of irregular T2
hypointense septations within it, which enhanced with
contrast. The mass was also found to displace flexor digi-
torum superficialis (FDS) tendons to the ring and little
fingers in a volo-ulnar direction and the FDS tendons to
the index and middle finger in a volo-radial direction (Fig.
2c, d). The median nerve was compressed anteriorly
between the FDS tendon slips to the middle and index fin-
gers and the overlying flexor retinaculum (Fig. 2c, d).
Associated T2 hyperintensity of the median nerve was
demonstrated over its passage through the carpal tunnel.
An excisional biopsy with marginal margins was subse-
quently performed. A longitudinal incision was made
over the volar aspect of the wrist and hand, entering the
carpal tunnel from its radial aspect. The mass was con-
firmed to be attached to the profundus tendon sheath of
the index finger and was excised from this surface.
Materials and methods
Hematoxylin and eosin-stained sections were examined.
Immunohistochemistry, involving streptavidin-biotin
peroxidase, was performed on formalin-fixed, paraffin-
embedded tumour specimens to keratins AE1/AE3 (Novo
Castra, Newcastle Upon Tyne, UK; 1/80 v), neuron-spe-
cific enolase (NSE) (DakoCytomation, Denmark; 1/1000
v), glial fibrillary acid protein (GFAP) (DakoCytomation,
Denmark; 1/5000 v), S100 protein (DakoCytomation,
Denmark; 1/8000 v), smooth muscle actin (SMA) (Dako-
Cytomation, Denmark; 1/200 v), and synaptophysin
(DakoCytomation, Denmark; 1/100 v). Diaminobenzi-
dine was used as the chromogen.
Pathological findings
Histological examination revealed a nodular lesion com-
posed of large epithelioid cells, singly and in clusters float-
ing in a loose myxoid/chondroid stroma (Fig. 3a, b). The
cells contained abundant eosinophilic cytoplasm, some
Thallium-201 scintigraphy at a) 30 minutes demonstrates  focal uptake in the right wrist (arrow), and b) at four hours,  wash-out in this area had occurred Figure 1
Thallium-201 scintigraphy at a) 30 minutes demon-
strates focal uptake in the right wrist (arrow), and b) 
at four hours, wash-out in this area had occurred.
a b
MRI of the lesion (L) shows it a) attached to the index finger  profundus tendon in the coronal plane on T1 weighted imag- ing, b) demonstrating septal enhancement post contrast  administration, c) displacing the superficialis tendons (T) to  the middle and index fingers radially on axial T1 imaging, and  d) showing heterogeneous T2 hyperintensity again in the  axial plane, with the compressed median nerve (N) more  clearly visualised Figure 2
MRI of the lesion (L) shows it a) attached to the index 
finger profundus tendon in the coronal plane on T1 
weighted imaging, b) demonstrating septal enhance-
ment post contrast administration, c) displacing the 
superficialis tendons (T) to the middle and index fin-
gers radially on axial T1 imaging, and d) showing het-
erogeneous T2 hyperintensity again in the axial 
plane, with the compressed median nerve (N) more 
clearly visualised.
a b
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N T
L
LInternational Seminars in Surgical Oncology 2009, 6:15 http://www.issoonline.com/content/6/1/15
Page 4 of 7
(page number not for citation purposes)
of which were multivacuolated or "physaliferous". The
nuclei showed mild atypia but no mitoses were seen.
Peripheral tumours with chondroid stroma include chon-
drosarcoma, ESMC, and ossifying fibromyxoid tumour
(OFT). Chondrosarcoma was excluded by positive keratin
markers and OFT was excluded by the clinical appearance,
soft consistency and lack of ossifying and firm fibrous
areas. ESMC demonstrates similar clinical and histologi-
cal features to the reported lesion, but myoepithelioma
was favoured, because of positive cytokeratins, GFAP
staining (Fig. 3c, d), and S100 [3,4]. Table 2 summarises
the immunohistochemical profile of our reported
tumour, and the percentage of previously reported
myoepitheliomas and ESMC staining positive for the
same markers.
Discussion
Myoepithelial tumours are a class of primary soft tissue
tumours that are becoming more frequently recognised,
probably as a result of the increasing number and range of
immunoperoxidase stains. The World Health Organisa-
tion (WHO) classification of tumours gives mixed tumour
and parachordoma as synonyms of myoepithelial
tumours [1]. Approximately 40% of tumours within this
spectrum are considered malignant [4], and have been
referred to by Hornick and Fletcher as myoepithelial car-
cinomas. This malignant variant is more likely to occur in
children [5]. The term myoepithelioma is more synony-
mous with a benign, although potentially locally recur-
rent, lesion.
Myoepitheliomas are found in the deep tissue planes in
the extremities. Tumours in cutaneous planes are consid-
ered tumours of skin appendages rather than primary soft
tissue tumours. A rare case, reported by Alberghini and co-
workers [6], was found to arise from bone and metasta-
sised to the lung.
In the myoepithelioma series of Hornick and Fletcher [4]
the gender distribution was essentially equal with 52%
male and 48% female. The age range was 3 to 83 years,
with the mean at 38 years and most frequently presenting
between the 3rd and 5th decades.
The defining histological characteristics of these tumours
are a lobular pattern on low power microscopy, a myxoid
or chondroid matrix and an epithelial component which
may have plasmacytoid, spindle and clear cell features
(Fig. 3). Immunoperoxidase staining is essential to the
diagnosis and the characteristic features are shown in
Table 2.
There are a number of important differential diagnoses for
myoepithelioma arising in the carpal tunnel. Extraskeletal
myxoid chondrosarcoma (ESMC), which has already
been mentioned, is often associated with tendons supply-
ing the hand, and can show very similar myxoid and
chondroid matrix features to myoepithelioma. In our
patient it was excluded mainly by positive cytokeratin
markers [3]. We were particularly concerned about ruling
out malignant chondroid lesions given that an initial
biopsy had shown synovial chondromatosis, and this can
be a precursor for chondrosarcoma [7]. Limited evidence
suggests that transformation of benign lesions within the
myoepithelioma spectrum is possible [4,8,9]. In hind-
sight it is clear that the initial core biopsy was not repre-
sentative and showed tissue at the junction of tumour and
normal tissue. Therefore, it is most likely that such inher-
ent difficulties in tumour biopsy contributed to a revised
diagnosis rather than any transformation within the
lesion.
Synovial sarcoma arises in similar peripheral locations to
myoepithelioma and can also demonstrate myxoid areas
and positive cytokeratin markers. It is differentiated from
myoepithelioma on the basis of negative SMA and GFAP
staining [10], and also its predominantly fibroblastic/
spindle cell cytology, although there are biphasic features
in 15% [11].
Malignant peripheral nerve sheath tumour (MPNST) is
also an important diagnosis to exclude given the proxim-
Histopathology of the excisional biopsy specimen demon- strates a) lobules of chondroid/myxoid matrix with embed- ded vacuolated cells and plasmacytoid cells (100×), b) these  same cell populations are shown at high-power (400×), c)  positive cytokeratin AE1-3 staining (200×), and d) weak  GFAP staining (200×) Figure 3
Histopathology of the excisional biopsy specimen 
demonstrates a) lobules of chondroid/myxoid matrix 
with embedded vacuolated cells and plasmacytoid 
cells (100×), b) these same cell populations are 
shown at high-power (400×), c) positive cytokeratin 
AE1-3 staining (200×), and d) weak GFAP staining 
(200×).International Seminars in Surgical Oncology 2009, 6:15 http://www.issoonline.com/content/6/1/15
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ity to the median nerve, and its usual epithelioid mor-
phology. MPNST also shares S100 expression and a
myxoid stroma [12] with myoepithelioma. A key diagnos-
tic feature of MPNST is the observation of tumour arising
directly from a peripheral nerve, or a benign neural
tumour on imaging. While our reported tumour was
impinging on the median nerve, it appeared to arise from
tendon on both MRI and intraoperatively.
Epithelioid sarcoma, again a key differential for a mass in
the wrist or hand, while cytokeratin positive [11], is easier
to differentiate from myoepithelioma because it generally
lacks myxoid and chondroid stroma.
Ossifying fibromyxoid tumour (OFT) is a benign,
although locally recurring lesion, with distinct similarities
to myoepithelioma such as a lobular architecture, epithe-
lioid component, myxoid matrix and focal bone forma-
tion [13]. Furthermore, OFT is S100 positive, and
occasionally positive for cytokeratins and GFAP. The
lesion presents with a firm, fibrous capsule and an ossify-
ing rim in around half of cases [13], and while myoepithe-
lioma may also contain bone, it is only present in around
10% of cases [4]. Another distinguishing feature, although
not performed in our case, is absent p63 staining [13], in
contrast to 23% of myoepitheliomas being p63 positive
[4].
In regard to clinicopathological correlation, Hornick and
Fletcher [4] studied 101 cases of myoepithelioma with
their main criteria for a malignant classification being
moderate to severe cytological atypia. These tumours were
noted to recur locally in 42%, and metastasise in 32% of
cases. On the other hand, cytologically bland tumours
only recurred locally in 18% and none metastasised. In
myoepithelioma of the upper limb, the risk of local recur-
rence appears to be even less with only 3 of 20 reported
cases (15%) recurring locally (Table 1). Surprisingly, infil-
trative features on histology (noted by Savera et al [14])
do not correlate with recurrence and metastasis, and very
little data exists on the influence of surgical margins
(Table 1).
Mitotic rate in malignant salivary myoepitheliomas has
been thought to be associated with an increased risk of
death from disease although this is only based on a very
small number of cases [15]. Darvishian and Lin [16]
described malignant features of myoepithelial carcinoma
arising mainly in the salivary glands, being pleomor-
phism, prominent nucleoli, mitotic figures, coarse chro-
matin and necrosis. In contrast, eight related benign
lesions (all pleomorphic adenoma) demonstrated no evi-
dence of these features. While myoepitheliomas and
mixed tumours are well recognised in salivary glands,
given the relatively small published numbers of soft tissue
myoepithelial tumours, it is not yet established that prog-
nostic features for salivary tumours are directly applicable
to these peripheral soft tissue tumours.
Space-occupying lesions are an uncommon cause of car-
pal tunnel syndrome, accounting for around 5% of cases,
and strongly linked to a unilateral presentation with 35%
of these patients having a space-occupying lesion [17].
This emphasises the importance of adequate investigation
in unilateral carpal tunnel syndrome. Tumours reported
in the carpal tunnel include ganglions [17], lipoma [18],
haemangioma [19], fibroma [20], and synovial sarcoma
[21]. Incidentally, extraskeletal chondroma, which is
related to our initial diagnosis of synovial chondromato-
sis, has also been published in regard to a carpal tunnel
location and association with profundus tendons [22].
The only other published case of myoepithelioma in the
wrist causing median nerve compression [2] was similar
to this reported case in having mild nuclear atypia, few
mitoses, and being S100 and cytokeratin positive but SMA
negative. A local but complete excision demonstrated no
evidence of recurrence at 5 months post surgery.
In the carpal tunnel, the major dilemma associated with
the resection of lesions with variable malignant potential
concerns the option of curative surgery with wide margins
which will permanently compromise hand function, ver-
sus a marginal/intralesional excision, which requires
accepting a degree of recurrence risk and the potential for
re-excision. As discussed, myoepithelial tumours can dis-
Table 2: A profile of immunohistochemical markers staining positive or negative in the reported tumour tissue
Antibody Reported tumour Expected ME [4] Expected ESMC [3]
Cytokeratin + 77% 1%
NSE + + [1] 54%
SYN +/- + [1] 59%
GFAP + 46% 2%
SMA - 36% 6%
S100 + 87% 31%
ME (myoepithelioma), ESMC (extra-skeletal myxoid chondrosarcoma)
This is compared with the percentage of positive staining reported in other cases of myoepithelioma and extraskeletal myxoid chondrosarcoma.International Seminars in Surgical Oncology 2009, 6:15 http://www.issoonline.com/content/6/1/15
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play subtle features of malignancy, and there is a reported
18% risk of local recurrence in lesions with low-grade
cytology [4]. Hornick and Fletcher demonstrated no cor-
relation between quality of margins and recurrence risk
[4], and so a clear consensus on surgical management is
lacking, although wide margin resection appears to be
well utilised [23]. In our case, the decision to perform a
marginal excision was much easier as it was based on the
perception that we were operating on synovial chondro-
matosis. In retrospect, and on the basis of Hornick and
Fletcher's data, we still see this as the best option for his-
tologically bland myoepithelioma within the carpal tun-
nel.
Conclusion
This case demonstrates the challenge of diagnosing
myoepithelioma, and differentiating it from other benign
and malignant tumours. It shows that even when using CT
guided core biopsy, a widely respected diagnostic tech-
nique, tissue samples may not adequately represent the
true diagnosis. The difficulty in diagnosing myoepitheli-
oma is also related to its rarity and similarity to ESMC.
Differentiation relies on meticulous scrutiny of cell mor-
phology and immunohistochemistry. While distal upper
limb myoepithelioma is likely to be low grade or benign,
there are still relatively few cases reported in this location,
and so careful follow-up is advised.
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